|
3-prop-2-enylsulfanyl-6-thiophen-2-yl-4H-1,2,4-triazin-5-one |
|
Klebsiella Pseudomonas |
Capsule; LPS LPS |
Preclinical (in vivo) Preclinical (in vivo) |
Benghezal M, et al. 2007. Cell Microbiol
|
|
3-Allylthio-1,2,4-triazin-5-one |
Depiction based on curated SMILES
CH
2
S
N
N
H
3
C
HO
N
|
Klebsiella Pseudomonas |
Capsule; LPS LPS |
Preclinical (in vivo) Preclinical (in vivo) |
Benghezal M, et al. 2007. Cell Microbiol
|
|
2,2'-thiobis(4-methylphenol) |
Depiction based on curated SMILES
OH
CH
3
CH
3
S
HO
|
Pseudomonas Yersinia |
TTSS (Type III secretion system) TTSS (Type III secretion system) |
Preclinical (in vitro) Preclinical (in vitro) |
Jessen DL, et al. 2014. Antimicrob Agents Chemother
|
|
N-benzyl-2-{[5,6-bis(4-methylphenyl)-1,2,4-triazin-3-yl]thio}acetamide |
Depiction based on curated SMILES
CH
3
N
CH
3
NH
O
S
N
N
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Starkey M, et al. 2014. PLoS Pathog |
|
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |